Orange Book product · Generic (ANDA)
DESONIDE
DESONIDE
At a glance
Nov 20, 2019
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Nov 20, 2019
6 yr 8 mo ago
Today
Pharmaceutical detail
Active ingredient
DESONIDE
Strength
0.05%
Dosage form
CREAM
Route
TOPICAL
TE code
AB
Application
ANDA 210198
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
Yes
Active-ingredient family
View full familyGeneric (ANDA) of DESONIDE
- 2006DESONATEBrand (NDA)
NDA 021844 · LEO PHARMA AS
- 2006VERDESOBrand (NDA)
NDA 021978 · GENUS
- 1984DESOWENBrand (NDA)
NDA 019048 · GALDERMA LABS LP
- —DESONIDEBrand (NDA)
NDA 017010 · PADAGIS US
- —DESONIDEBrand (NDA)
NDA 017426 · PADAGIS US
- 2022DESONIDEGeneric (ANDA)
ANDA 214396 · ALEMBIC
- 2020DESONIDEGeneric (ANDA)
ANDA 213632 · ALEMBIC
- 2020DESONIDEGeneric (ANDA)
ANDA 202470 · SENORES PHARMS
- 2019DESONIDEGeneric (ANDA)
ANDA 212473 · ALEMBIC
- 2019DESONIDEGeneric (ANDA)
ANDA 212002 · PAI HOLDINGS PHARM
- 2019DESONIDEGeneric (ANDA)
ANDA 210998 · ENCUBE ETHICALS
- 2017DESONIDEGeneric (ANDA)
ANDA 207855 · ENCUBE
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
